Will COVID Finally Help US FDA And Sponsors Overcome Their ‘Angst’ On Innovative Trial Designs?

The ‘sea change’ inside White Oak should be seen as very encouraging for sponsors, FDA official says.

BIO International Convention clinical trial lessons learned screenshot
FDA and industry experts discuss clinical trial design lessons learned from the COVID-19 pandemic during the BIO International Convention. • Source: Screenshot

More from Clinical Trials

More from R&D